Abstract

In this study, two stereocomplementary ω-transaminases from Arthrobacter sp. (AsR-ωTA) and Chromobacterium violaceum (Cv-ωTA) were immobilized via iron cation affinity binding onto polymer-coated controlled porosity glass beads (EziG™). The immobilization procedure was studied with different types of carrier materials and immobilization buffers of varying compositions, concentrations, pHs and cofactor (PLP) concentrations. Notably, concentrations of PLP above 0.1 mM were correlated with a dramatic decrease of the immobilization yield. The highest catalytic activity, along with quantitative immobilization, was obtained in MOPS buffer (100 mM, pH 8.0, PLP 0.1 mM, incubation time 2 h). Leaching of the immobilized enzyme was not observed within 3 days of incubation. EziG-immobilized AsR-ωTA and Cv-ωTA retained elevated activity when tested for the kinetic resolution of rac-α-methylbenzylamine (rac-α-MBA) in single batch experiments. Recycling studies demonstrated that immobilized EziG3-AsR-ωTA could be recycled for at least 16 consecutive cycles (15 min per cycle) and always affording quantitative conversion (TON ca. 14,400). Finally, the kinetic resolution of rac-α-MBA with EziG3-AsR-ωTA was tested in a continuous flow packed-bed reactor (157 μL reactor volume), which produced more than 5 g of (S)-α-MBA (>49% conversion, >99% ee) in 96 h with no detectable loss of catalytic activity. The calculated TON was more than 110,000 along with a space-time yield of 335 g L−1 h−1.

Highlights

  • Industrial application of biocatalysts has been expanding, in the pharmaceutical and fine chemical industries (Choi et al, 2015; Madhavan et al, 2017; Prasad and Roy, 2018; Schmid et al, 2001)

  • We studied the conditions for the optimal immobilization of two stereocomplementary ω-transaminases on EziG carrier materials based on the use of different types of immobilization buffers at varied concentrations of PLP cofactor

  • The optimal conditions for immobilization on EziG carrier were found to be the use of 100 mM MOPS buffer supplemented with 0.1 mM PLP

Read more

Summary

Introduction

Industrial application of biocatalysts has been expanding, in the pharmaceutical and fine chemical industries (Choi et al, 2015; Madhavan et al, 2017; Prasad and Roy, 2018; Schmid et al, 2001). Because of their low environmental impact, elevated catalytic efficiency and exquisite selectivity, enzymes are an appealing option for the synthesis of many high value compounds in batch- as well as continuous flow reactors (Sheldon and Woodley, 2018). Other disadvantages of biocatalytic processes using whole cells include the lower volumetric productivities and the frequent occurrence of cell breakage; the latter process generates debris that can contaminate the reaction medium

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call